Aurobindo Pharma eyes European business of Apotex

The deal may be valued at around $100 million and fits in with Aurobindo ’s strategic road map of upping its presence in eastern Europe through bolt-on acquisitions, two sources told ET.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news